MSL
ARNA

Mackay Shields LLC’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Mackay Shields LLC’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,191
Closed -$1.68M – 1459
2021
Q1 		$1.68M Sell
24,191
-16,589
-41% -$1.28M 0.01% 837
2020
Q4 		$3.13M Sell
40,780
-2,500
-6% -$187K 0.02% 650
2020
Q3 		$3.24M Buy
43,280
+2,700
+7% +$180K 0.02% 581
2020
Q2 		$2.56M Buy
40,580
+1,700
+4% +$93.5K 0.02% 651
2020
Q1 		$1.63M Buy
38,880
+2,800
+8% +$128K 0.02% 756
2019
Q4 		$1.64M Sell
36,080
-2,700
-7% -$128K 0.01% 947
2019
Q3 		$1.77M Sell
38,780
-1,700
-4% -$95.6K 0.01% 944
2019
Q2 		$2.37M Buy
40,480
+23,289
+135% +$1.2M 0.02% 833
2019
Q1 		$771K Buy
17,191
+200
+1% +$9.17K 0.01% 1071
2018
Q4 		$662K Buy
+16,991
New +$667K 0.01% 1076
2018
Q3 		– Sell
-17,242
Closed -$751K – 1259
2018
Q2 		$751K Buy
17,242
+300
+2% +$12.9K 0.01% 1024
2018
Q1 		$669K Buy
+16,942
New +$659K ﹤0.01% 1068

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mackay Shields LLC's ARNA Position: Q2 2021 in Review

Mackay Shields LLC sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 24,191 shares — an estimated $1.68M sold.

Mackay Shields LLC first reported a position in ARNA in Q1 2018 and held it in 12 quarters. The position peaked at $3.24M in Q3 2020. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • Mackay Shields LLC reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 24,191 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $1.68M.
  • Mackay Shields LLC first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 12 quarters.
  • Mackay Shields LLC's Arena Pharmaceuticals Inc position peaked at $3.24M in Q3 2020.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.